Literature DB >> 22735886

Clinical heterogeneity of desmoplastic infantile ganglioglioma: a case series and literature review.

Trent R Hummel1, Lili Miles, Francesco T Mangano, Blaise V Jones, James I Geller.   

Abstract

Desmoplastic infantile gangliogliomas (DIG) are intracranial tumors described in 1987 as benign lesions of infancy. A literature review and the clinical course of 3 patients reported herein suggest that the initial description should be amended. Nearly 23% of DIG cases occur in children older than 24 months. Approximately 40% of DIG cases require additional medical, radiation, and/or further surgical intervention, and 15% of infants and children develop leptomeningeal spread or die from DIG. Such adverse outcomes, combined with the recognition that DIG represents a heterogeneous disease, underscore the need for an expanded biological and molecular investigation.

Entities:  

Mesh:

Year:  2012        PMID: 22735886     DOI: 10.1097/MPH.0b013e3182580330

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  8 in total

1.  Novel suprasellar location of desmoplastic infantile astrocytoma and ganglioglioma: a single institution's experience.

Authors:  Ryan M Naylor; Anton Wohl; Aditya Raghunathan; Laurence J Eckel; Gesina F Keating; David J Daniels
Journal:  J Neurosurg Pediatr       Date:  2018-07-06       Impact factor: 2.375

Review 2.  Diffusion, Perfusion, and Histopathologic Characteristics of Desmoplastic Infantile Ganglioglioma.

Authors:  Chang Y Ho; Melissa Gener; Jose Bonnin; Stephen F Kralik
Journal:  J Radiol Case Rep       Date:  2016-07-31

3.  Desmoplastic infantile astrocytoma/ganglioglioma with rare BRAF V600D mutation.

Authors:  Ashley Greer; Nicholas K Foreman; Andrew Donson; Kurtis D Davies; B K Kleinschmidt-DeMasters
Journal:  Pediatr Blood Cancer       Date:  2016-11-10       Impact factor: 3.167

4.  Desmoplastic infantile astrocytoma and ganglioglioma: a series of 12 patients treated at a single institution.

Authors:  Alessia Imperato; Pietro Spennato; Federica Mazio; Esperanza Arcas; Onur Ozgural; Lucia Quaglietta; Maria Elena Errico; Giuseppe Cinalli
Journal:  Childs Nerv Syst       Date:  2021-01-28       Impact factor: 1.475

5.  The molecular characteristics of low-grade and high-grade areas in desmoplastic infantile astrocytoma/ganglioglioma.

Authors:  Jason Chiang; Xiaoyu Li; Hongjian Jin; Gang Wu; Tong Lin; David W Ellison
Journal:  Neuropathol Appl Neurobiol       Date:  2022-03-01       Impact factor: 6.250

6.  Predictors of mortality and tumor recurrence in desmoplastic infantile ganglioglioma and astrocytoma-and individual participant data meta-analysis (IPDMA).

Authors:  Shelly Wang; Matthew Z Sun; I Joshua Abecassis; Alexander G Weil; George M Ibrahim; Aria Fallah; Chibawanye Ene; Sarah E S Leary; Bonnie L Cole; Christina M Lockwood; James M Olson; J Russell Geyer; Richard G Ellenbogen; Jeffrey G Ojemann; Anthony C Wang
Journal:  J Neurooncol       Date:  2021-10-06       Impact factor: 4.506

7.  Establishment and Characterization of Brain Cancer Primary Cell Cultures From Patients to Enable Phenotypic Screening for New Drugs.

Authors:  Michelle dePadua; Preethi Kulothungan; Rahul Lath; Ravikanti Prasad; Kranthi Madamchetty; Shravya Atmakuri; Sravanthi Ragamouni; Mukesh Gandhari; Lakshmipathi Khandrika; Jugnu Jain
Journal:  Front Pharmacol       Date:  2022-03-17       Impact factor: 5.810

8.  Inflammatory myofibroblastic lung tumor transforming into intracranial desmoplastic noninfantile ganglioglioma: A case report and literature review.

Authors:  Fu Wei; Seidu A Richard; Junya Tan; Zhigang Lan; Yan Ju
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.